Calliditas Therapeutics AB (publ)
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Calliditas Therapeutics AB (publ) generated cash of -$434,655,000, which is less than the previous year. Cash used in financing activities reached the amount of $199,650,000 last year. Net change in cash is therefore -$275,361,000.
Cash Flow
| 2015 | -48.91M | -290K | 55.18M |
|---|---|---|---|
| 2016 | -55.43M | -256K | 54.72M |
| 2017 | -68.00M | -50K | 101.22M |
| 2018 | -128.19M | 0 | 716.57M |
| 2019 | -71.01M | -18.07M | 198.83M |
| 2020 | -309.18M | -172.60M | 768.55M |
| 2021 | -461.58M | -24.34M | 435.16M |
| 2022 | -311.35M | -5.14M | 575.99M |
| 2023 | -434.65M | -13.74M | 199.65M |
CALT Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.24B | 955.50M | 996.30M | 753.54M | 656.17M | 57.35M | 24.24M | 25.16M | 19.19M |
Operating activities | |||||||||
Net income | -466.18M | -421.94M | -524.45M | -379.72M | -28.01M | -132.48M | -84.50M | -56.02M | -50.91M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 16.59M | 12.91M | 34.43M | 2.82M | 1.82M | 51K | 51K | 112K | 111K |
Stock-based compensation expense | 52.59M | 35.79M | 21.96M | 6.01M | 249K | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 52.59M | 35.79M | 21.96M | 6.01M | 249K | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -182.58M | -91.87M | -11.71M | 8.03M | -53.54M | 0 | -1.88M | 0 | -1.18M |
Inventories | -16.78M | -2.75M | -949K | 0 | 45.90M | 0 | 0 | 0 | 0 |
Accounts payable | 119.62M | 183.05M | 18.13M | 46.05M | 7.64M | 0 | 18.06M | 0 | 3.17M |
Cash generated by operating activities | -434.65M | -311.35M | -461.58M | -309.18M | -71.01M | -128.19M | -68.00M | -55.43M | -48.91M |
Investing activities | |||||||||
Purchases Of Investments | -1.56M | -2.63M | -1.68M | -5K | -1.88M | 0 | -50K | 0 | -290K |
Investments In Property Plant And Equipment | -12.78M | -2.51M | -22.65M | 0 | -16.18M | 0 | 0 | -256K | 0 |
Acquisitions Net | 0 | 0 | -47.02M | -172.60M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -13.74M | -5.14M | -24.34M | -172.60M | -18.07M | 0 | -50K | -256K | -290K |
Financing activities | |||||||||
Common Stock Issued | 0 | 236K | 303.09M | 854.70M | 210.31M | 768.64M | 64.75M | 24.72M | 55.12M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -236K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 226.27M | 482.13M | -193.94M | -3.97M | -1.65M | -470K | 36.31M | 0 | 0 |
Cash used in financing activities | 199.65M | 575.99M | 435.16M | 768.55M | 198.83M | 716.57M | 101.22M | 54.72M | 55.18M |
Net Change In Cash | -275.36M | 293.58M | -40.79M | 242.76M | 97.36M | 588.82M | 33.11M | -921K | 5.96M |
Cash at end of period | 973.73M | 1.24B | 955.50M | 996.30M | 753.54M | 646.17M | 57.35M | 24.24M | 25.16M |
| Data source | Data source | Data source | Data source |